Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
Hahn
H J
HJ
Institute of Immunology, Free University Berlin, Germany.
Kuttler
B
B
Dunger
A
A
Lucke
S
S
Volk
H D
HD
Diamantstein
T
T
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000601:surgery*; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D017710:Lymphocyte Transfusion; D051381:Rats; D011913:Rats, Inbred BB; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D014185:Transplantation, Isogeneic
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D015375:Receptors, Interleukin-2